In a baffling decision that could harm the poorest patients, the World Health Organization (WHO) told global physicians Friday not to prescribe remdesivir – even though it is the only COVID-19 treatment approved by the world’s top pharmaceutical regulator, the U.S. Food & Drug Administration (FDA).
The WHO, under fire for its slow start against the global pandemic, decided to shun the FDA and base a decision on its own study. That study, still incomplete, used methods inferior to the National Institutes of Health (NIH) trial that confirmed the efficacy and safety of the COVID drug, now called in many countries by its brand name Veklury.
Read Full Article »